Veterans' Foundation grants £20,000 to Pioneer Programme
This award brings the MDMA-assisted therapy trials a step closer to UK veterans
12 August 2021
SWV has been awarded a new grant of £20,000 to support its campaign to bring MDMA-assisted therapy to the UK. The Pioneer Programme consists of two clinical trials of MDMA-assisted therapy for veterans with severe PTSD, delivered by King’s College London in association with MAPS (Multidisciplinary Association of Psychedelic Studies) in the US.
It will build on many years of research in the US, and the very encouraging outcomes of the Phase 3 trials there.
Army veteran Martin served just shy of 16 years but was discharged with Complex PTSD. Speaking about SWV’s Pioneer Programme, Martin said:
“To have a new life, to have a world where my PTSD is not as dominating as it is right now. It would be giving me a chance to have a new life….what a wonderful gift that would be.”
Gilly Norton, Chief Executive of Supporting Wounded Veterans said:
“We are incredibly grateful to the Veterans’ Foundation for their generous grant. The grant will support the delivery of our Pioneer Programme.”
The Veterans’ Foundation have given away £7.1m since inception and we predict giving away grants amounting to £4.5m in the next 12 months. This is made possible by donations and players of the Veterans’ Lottery – thank you to everyone involved.